Oxford Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Oxford Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,521	Closed	-$1.74M	–	1368
2019 Q4	$1.74M	Sell	10,521 -4,960	-32%	-$824K	0.05%	506
2019 Q3	$1.9M	Buy	15,481 +7,534	+95%	+$1M	0.05%	580
2019 Q2	$985K	Buy	7,947 +1,838	+30%	+$233K	0.02%	988
2019 Q1	$806K	Buy	+6,109	New	+$824K	0.02%	1034
2018 Q4	–	Sell	-6,171	Closed	-$1.07M	–	2158
2018 Q3	$1.07M	Sell	6,171 -3,789	-38%	-$637K	0.02%	980
2018 Q2	$1.54M	Buy	+9,960	New	+$1.78M	0.03%	818

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Oxford Asset Management's ONC Position: Q1 2020 in Review

Oxford Asset Management sold out of BeOne Medicines Ltd (ONC) in Q1 2020, closing a stake of 10,521 shares — an estimated $1.74M sold.

Oxford Asset Management first reported a position in ONC in Q2 2018 and held it in 6 quarters. The position peaked at $1.9M in Q3 2019. 215 funds tracked by Wall St. Rank hold ONC as of Q1 2020.

Oxford Asset Management reported no remaining BeOne Medicines Ltd position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 10,521 BeOne Medicines Ltd shares in Q1 2020, an estimated $1.74M.
Oxford Asset Management first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 6 quarters.
Oxford Asset Management's BeOne Medicines Ltd position peaked at $1.9M in Q3 2019.
215 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.